Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative advanced breast cancer in the United States

Journal of Medical Economics, 1-26, November 16, 2012

View abstract

Authors

Xie J, Diener M, De G, Yang H, Wu EQ, Namjoshi M